The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...
Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...
This hypercar boasts a blend of race-inspired aerodynamics and scissor doors. Under the hood, the F80 features a hybrid powertrain, combining a V6 turbo engine with three electric motors. Together, ...